Matthew Brook

3.0k total citations
20 papers, 2.6k citations indexed

About

Matthew Brook is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Matthew Brook has authored 20 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Matthew Brook's work include RNA Research and Splicing (12 papers), RNA modifications and cancer (4 papers) and RNA regulation and disease (4 papers). Matthew Brook is often cited by papers focused on RNA Research and Splicing (12 papers), RNA modifications and cancer (4 papers) and RNA regulation and disease (4 papers). Matthew Brook collaborates with scholars based in United Kingdom, United States and Netherlands. Matthew Brook's co-authors include Andrew R. Clark, Jeremy Saklatvala, Jonathan L. E. Dean, Gareth Sully, Nicola K. Gray, Kamal R Mahtani, Marina Lasa, Danuta Radzioch, Edward Hitti and Alexey Kotlyarov and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Matthew Brook

20 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Brook United Kingdom 17 1.7k 636 628 494 325 20 2.6k
Jonathan L. E. Dean United Kingdom 30 2.2k 1.4× 844 1.3× 996 1.6× 653 1.3× 371 1.1× 41 3.5k
Ping‐Hui Tseng Taiwan 25 1.7k 1.0× 871 1.4× 1.3k 2.1× 512 1.0× 312 1.0× 36 3.2k
Elke Boone Belgium 14 1.0k 0.6× 784 1.2× 797 1.3× 507 1.0× 109 0.3× 27 2.2k
Bartholomew J. Votta United States 19 1.4k 0.9× 297 0.5× 450 0.7× 569 1.2× 182 0.6× 30 2.5k
Arndt Schottelius Germany 21 1.3k 0.8× 623 1.0× 1.0k 1.6× 692 1.4× 177 0.5× 27 3.0k
Denise M. Ray United States 16 924 0.6× 314 0.5× 526 0.8× 265 0.5× 436 1.3× 18 2.1k
Nywana Sizemore United States 20 1.3k 0.8× 836 1.3× 798 1.3× 625 1.3× 120 0.4× 31 2.5k
Manfred Neumann Germany 29 1.6k 0.9× 939 1.5× 1.3k 2.0× 629 1.3× 122 0.4× 54 3.1k
Lesley Rawlinson United Kingdom 12 1.4k 0.9× 416 0.7× 648 1.0× 469 0.9× 105 0.3× 13 2.1k
Chang-Hoon Woo South Korea 34 1.4k 0.9× 416 0.7× 719 1.1× 315 0.6× 125 0.4× 53 2.6k

Countries citing papers authored by Matthew Brook

Since Specialization
Citations

This map shows the geographic impact of Matthew Brook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Brook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Brook more than expected).

Fields of papers citing papers by Matthew Brook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Brook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Brook. The network helps show where Matthew Brook may publish in the future.

Co-authorship network of co-authors of Matthew Brook

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Brook. A scholar is included among the top collaborators of Matthew Brook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Brook. Matthew Brook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Hongling, Florentina Negoita, Matthew Brook, Kei Sakamoto, & Nicholas M. Morton. (2024). Quantification of persulfidation on specific proteins: are we nearly there yet?. Essays in Biochemistry. 68(4). 467–478. 1 indexed citations
2.
Brook, Matthew, Katherine Miles, Richard W. Smith, et al.. (2016). Neutrophil-derived alpha defensins control inflammation by inhibiting macrophage mRNA translation. Proceedings of the National Academy of Sciences. 113(16). 4350–4355. 67 indexed citations
3.
4.
Friend, Kyle, et al.. (2012). Embryonic poly(A)-binding protein (ePAB) phosphorylation is required for Xenopus oocyte maturation. Biochemical Journal. 445(1). 93–100. 25 indexed citations
5.
Brook, Matthew & Nicola K. Gray. (2012). The role of mammalian poly(A)-binding proteins in co-ordinating mRNA turnover. Biochemical Society Transactions. 40(4). 856–864. 36 indexed citations
6.
7.
Smith, Richard, et al.. (2011). DAZAP1, an RNA-binding protein required for development and spermatogenesis, can regulate mRNA translation. RNA. 17(7). 1282–1295. 40 indexed citations
8.
Gorgoni, Barbara, William Richardson, Hannah M. Burgess, et al.. (2011). Poly(A)-binding proteins are functionally distinct and have essential roles during vertebrate development. Proceedings of the National Academy of Sciences. 108(19). 7844–7849. 45 indexed citations
9.
Peirce, Matthew J., Matthew Brook, Nicholas A. Morrice, et al.. (2010). Themis2/ICB1 Is a Signaling Scaffold That Selectively Regulates Macrophage Toll-Like Receptor Signaling and Cytokine Production. PLoS ONE. 5(7). e11465–e11465. 35 indexed citations
10.
Salaün, Christine, Alasdair I. MacDonald, Hannah M. Burgess, et al.. (2010). Poly(A)-Binding Protein 1 Partially Relocalizes to the Nucleus during Herpes Simplex Virus Type 1 Infection in an ICP27-Independent Manner and Does Not Inhibit Virus Replication. Journal of Virology. 84(17). 8539–8548. 44 indexed citations
11.
Coldwell, Mark J., Nicola K. Gray, & Matthew Brook. (2010). Cytoplasmic mRNA: move it, use it or lose it!. Biochemical Society Transactions. 38(6). 1495–1499. 2 indexed citations
12.
Brook, Matthew, et al.. (2009). The DAZL and PABP families: RNA-binding proteins with interrelated roles in translational control in oocytes. Reproduction. 137(4). 595–617. 88 indexed citations
13.
14.
Brook, Matthew, Tomàs Santalucı́a, Joanne McIlrath, et al.. (2006). Posttranslational Regulation of Tristetraprolin Subcellular Localization and Protein Stability by p38 Mitogen-Activated Protein Kinase and Extracellular Signal-Regulated Kinase Pathways. Molecular and Cellular Biology. 26(6). 2408–2418. 223 indexed citations
15.
Brook, Matthew, et al.. (2004). The Stability of Tristetraprolin mRNA Is Regulated by Mitogen-activated Protein Kinase p38 and by Tristetraprolin Itself. Journal of Biological Chemistry. 279(31). 32393–32400. 135 indexed citations
16.
Mahtani, Kamal R, Matthew Brook, Jonathan L. E. Dean, et al.. (2001). Mitogen-Activated Protein Kinase p38 Controls the Expression and Posttranslational Modification of Tristetraprolin, a Regulator of Tumor Necrosis Factor Alpha mRNA Stability. Molecular and Cellular Biology. 21(19). 6461–6469. 390 indexed citations
17.
Lasa, Marina, Matthew Brook, Jeremy Saklatvala, & Andrew R. Clark. (2001). Dexamethasone Destabilizes Cyclooxygenase 2 mRNA by Inhibiting Mitogen-Activated Protein Kinase p38. Molecular and Cellular Biology. 21(3). 771–780. 223 indexed citations
18.
Brook, Matthew, Gareth Sully, Andrew R. Clark, & Jeremy Saklatvala. (2000). Regulation of tumour necrosis factor α mRNA stability by the mitogen‐activated protein kinase p38 signalling cascade. FEBS Letters. 483(1). 57–61. 197 indexed citations
19.
Dean, Jonathan L. E., Matthew Brook, Andrew R. Clark, & Jeremy Saklatvala. (1999). p38 Mitogen-activated Protein Kinase Regulates Cyclooxygenase-2 mRNA Stability and Transcription in Lipopolysaccharide-treated Human Monocytes. Journal of Biological Chemistry. 274(1). 264–269. 461 indexed citations
20.
Ridley, Simon H., Jonathan L. E. Dean, S J Sarsfield, et al.. (1998). A p38 MAP kinase inhibitor regulates stability of interleukin‐1‐induced cyclooxygenase‐2 mRNA. FEBS Letters. 439(1-2). 75–80. 191 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan L. E. Dean Breakdown of academic impact, for papers by Ping‐Hui Tseng Breakdown of academic impact, for papers by Elke Boone Breakdown of academic impact, for papers by Bartholomew J. Votta Breakdown of academic impact, for papers by Arndt Schottelius Breakdown of academic impact, for papers by Denise M. Ray Breakdown of academic impact, for papers by Nywana Sizemore Breakdown of academic impact, for papers by Manfred Neumann Breakdown of academic impact, for papers by Lesley Rawlinson Breakdown of academic impact, for papers by Chang-Hoon Woo
Rankless by CCL
2026